drugset
drugset / Trial / NCT03412500

Vancomycin Dosage Adjustment for MRSA Infections

NCT03412500 ↗

Phase 4 Unknown 114 enrolled Pinyo Rattanaumpawan
RandomizedParallel-groupOpen-labelTreatment

Summary

An open-label randomized controlled trial to compare two vancomycin dosage adjustment methods

Timeline

Start
2016-10
Primary completion
2018-09
Completion
2018-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified — —

Indications

methicillin-resistant staphylococcus aureus infectious disease